Latest News and Press Releases
Want to stay updated on the latest news?
Search Results
Everything
-
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリア メルボルン、CEO：Dr. Christian...
-
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
-
メルボルン , July 26, 2018 (GLOBE NEWSWIRE) -- および京都発 (グローブニューズワイヤ) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用･治療用製品の開発に注力するオーストラリアのバイオ製薬会社であるテリックス･ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX:TLX)...
-
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
-
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
-
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...